Concepedia

Muriel Busson

MB

32

Publications

1.7K

Citations

24

H-Index

2001

Active since

Affiliations

Inserm(Current)

Université de Montpellier

Institut de Recherche en Cancérologie de Montpellier

Centre National de la Recherche Scientifique

Institut Regional du Cancer de Montpellier

Muriel Busson is an author at Inserm specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

2001–2019

32

Publications

32

CXC chemokines located in the 4q21 region are up-regulated in breast cancer

Ivan Bièche, Carine Chavey, Catherine Andrieu et al. · Endocrine Related Cancer · 2007 · 177 citations · Full text

Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer

Carine Bossard, Muriel Busson, David Vindrieux et al. · PLoS ONE · 2012 · 111 citations · Full text

, , +20

Inhibition of <scp>DDR</scp> 1‐ <scp>BCR</scp> signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer

Maya Jeitany, Cédric Leroy, Priscillia Tosti et al. · EMBO Molecular Medicine · 2018 · 109 citations · Full text

Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis

Wilhem Leconet, Myriam Chentouf, Stanislas du Manoir et al. · Clinical Cancer Research · 2016 · 108 citations · Full text

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy

Wilhem Leconet, Christel Larbouret, Thierry Chardès et al. · Oncogene · 2013 · 104 citations · Full text

, , +5

Rows per page

1–5 of 32